KALV = 9.26 US dolair
+0.09 USD (+0.97%)
atharrachadh prìsean stoc bho an-dè
Tionndadh KalVista Pharmaceuticals, Inc. ann an US dolair aig an ìre chuibheasach gnàthach. Tha luach cuibheasach gach latha air prìs stoc cuòt stoc. Prìs stoc bho stòran dearbhte. Tha 1 stoc de KalVista Pharmaceuticals, Inc. a-nis 9.26 stoc de US dolair. 1 stoc de KalVista Pharmaceuticals, Inc. air a mheudachadh le 0.09 US dolair. Mheudaich an ìre KalVista Pharmaceuticals, Inc. an aghaidh US dolair le 98 ceudamh puing sa cheud.
|
KalVista Pharmaceuticals, Inc. luach co-roinnte a 'chompanaidh US dolair
O chionn mìos, dh ’fhaodadh KalVista Pharmaceuticals, Inc. a cheannach airson 0 US dolair. O chionn bliadhna, dh ’fhaodadh KalVista Pharmaceuticals, Inc. a reic airson 8.90 stoc de US dolair. O chionn trì bliadhna, dh ’fhaodadh KalVista Pharmaceuticals, Inc. a reic airson 25.06 US dolair. An seo chithear cairt de phrìs stoc airson diofar amannan. 0% - atharrachadh ann am prìs stoc KalVista Pharmaceuticals, Inc. ann an US dolair gach mìos. Thairis air a ’bhliadhna, KalVista Pharmaceuticals, Inc. ann an US dolair prìs stoc air atharrachadh le 4.04%.
|
Aithris stoc KalVista Pharmaceuticals, Inc. US dolair
KALV Gu US dolair (USD)
|
1 KALV |
9.26 US dolair |
5 KALV |
46.30 US dolair |
10 KALV |
92.60 US dolair |
25 KALV |
231.50 US dolair |
50 KALV |
463 US dolair |
100 KALV |
926 US dolair |
250 KALV |
2 315 US dolair |
500 KALV |
4 630 US dolair |
An-diugh, faodaidh tu 10 stoc de KalVista Pharmaceuticals, Inc. a thionndadh airson 92.60 US dolair. Ma tha 231.50 US dolair, an uairsin ann an Bhreatainn Virgin nan Eilean faodar an reic airson 25 stoc de KalVista Pharmaceuticals, Inc.. An-diugh, faodar 50 stoc de KalVista Pharmaceuticals, Inc. a iomlaid airson 463 US dolair. Tha tionndadh 100 stoc de KalVista Pharmaceuticals, Inc. a ’cosg 926 US dolair. Gus 250 stoc de KalVista Pharmaceuticals, Inc., 2 315 US dolair a thionndadh a dhìth. Ma tha 4 630 US dolair, an uairsin ann an Bhreatainn Virgin nan Eilean faodar an reic airson 500 stoc de KalVista Pharmaceuticals, Inc..
|